Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

IPC elects new three new board members

The International Psoriasis Council is governed by a volunteer board of directors comprised of the world’s leading experts in psoriasis who provide business expertise to the organization. We are excited to announce that three new key opinion leaders have been elected to join our board.

Meet our newest board members

Andrew Blauvelt, MD, MBA
Oregon Medical Research Center
Portland, Oregon, United States
IPC Board Member

Dr. Blauvelt is President of Oregon Medical Research Center, a small business dedicated to performing high quality clinical research studies in dermatology. He received his undergraduate degree in electrical engineering at Purdue University, his medical degree at Michigan State University, and a healthcare MBA at Oregon Health & Science University (OHSU). Dr. Blauvelt trained in dermatology at the University of Miami and in cellular immunology under the direction of Steve Katz at the National Institutes of Health (NIH). Earlier in his career, he held senior staff positions at the NIH (Senior Investigator), OHSU (Professor), and the Portland VA Medical Center (Chief). Dr. Blauvelt's research and clinical expertise has been in Langerhans cell biology, T cell immunology, virology, psoriasis, and atopic dermatitis. He has published over 300 papers and spoken across the country and world on these topics. Within psoriasis research, his laboratory published key papers on the role of IL-23/Th17 biology in psoriasis; in recent years, he has been the international lead investigator on a number of important clinical trials, including PSTELLAR, FEATURE, IXORA-R, VOYAGE 1, IMMhance, CHRONOS, ECZTEND, JADE REGIMEN, and HEADS UP. Dr. Blauvelt is also an elected member of the American Society for Clinical Investigation, the International Psoriasis Council, the International Eczema Council, and the Scientific Advisory Committee of the National Psoriasis Foundation. In 2021, he made the list of Highly Cited Researchers, representing the top 1% of cited scientists in the world.

Last Updated: Jan 26, 2022

Siew Eng Choon, MBBS, FRCP
Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia
Johor Bahru, Malaysia
IPC Board Member

Dr. Choon Siew Eng is a senior consultant dermatologist at Hospital Sultanah Aminah, Johor Bahru, Malaysia and Associate Professor, Clinical School Johor Bahru, Jeffrey Cheah School of Medicine and Health Sciences, Monash University, Malaysia. She received her medical degree from the University of Malaya. She subsequently undertook postgraduate training in general medicine and obtained membership of the Royal College of Physicians (London, UK)and was elected a fellow in 2003. She was awarded a public service scholarship to pursue dermatology training and subsequently a fellowship to train in dermatopathology in St. John’s Institute of Dermatology, London, UK. Dr. Choon is a foundation member of Asian Academy of Dermatology and Venereology and an active member of the Malaysian Society of Dermatology as well as a member of the Malaysian Medical Association. Her research interests include chronic inflammatory skin diseases namely atopic dermatitis, psoriasis particularly pustular psoriasis, hidradenitis suppurativa and cutaneous adverse drug reactions. She is a member of International Psoriasis Council and an advisor of the Psoriasis Association of Johor.

Last Updated: Jan 26, 2022

Catherine Smith, MD
St John's Institute of Dermatology, Guys and St Thomas's Hospitals
London, England, United Kingdom
IPC Board Member

Catherine is Professor of Dermatology and Therapeutics and Consultant Dermatologist at St John’s Institute of Dermatology, Kings College London and Guys and St Thomas’ Hospital.  She co-directs the Skin Therapy Research Unit, and is also a lead clinician in national specialised services for adults with severe psoriasis. Her clinical and research interests focus on inflammatory skin disease and translational medicine, extending from biomarker discovery through to interventional studies (phase II-IV), and involve major national and international collaboration.  She also has a major interest in guideline development and implementation in the UK and Europe, with the aim of bringing research findings into clinical practice.

Last Updated: Jan 26, 2022

A complete list of our Board of Directors with their full biographies can be found here.

Stay informed

Join the email list to receive the latest information on psoriasis meetings, manuscripts and research.

now available

COVID-19 Psoriasis Resource Center

Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve

explore now


on SARS-CoV-2 Vaccines and Psoriasis

Six key take-aways that physicians and other healthcare practitioners should consider when administering the SARS-CoV-2 vaccine to psoriasis patients.


We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.